239 related articles for article (PubMed ID: 32455150)
1. Lessons learnt from delayed diagnosis of FGF-23-producing tumour-induced osteomalacia and post-operative hungry bone syndrome.
Kumar S; Diamond T
Bone Rep; 2020 Jun; 12():100276. PubMed ID: 32455150
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced osteomalacia treated with T12 tumor resection.
Mancini AJ; Sabet A; Nielsen GP; Parker JA; Schwab JH; Ward A; Wu JS; Malabanan AO
Endocrinol Diabetes Metab Case Rep; 2022 Dec; 2022():. PubMed ID: 36511458
[TBL] [Abstract][Full Text] [Related]
3. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
4. Treating 'osteoporosis': a near miss in an unusual case of FGF-23-mediated hypophosphataemic osteomalacia.
Lin M; Ganda K
Endocrinol Diabetes Metab Case Rep; 2022 Nov; 2022():. PubMed ID: 36511449
[TBL] [Abstract][Full Text] [Related]
5. Selective blood sampling for FGF-23 in tumor-induced osteomalacia.
Schober HC; Kneitz C; Fieber F; Hesse K; Schroeder H
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 29026610
[TBL] [Abstract][Full Text] [Related]
6. Challenging case of tumour-induced osteomalacia.
Kumar P; Jadhav DV; Ravat SH; Jain N
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35589273
[TBL] [Abstract][Full Text] [Related]
7. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Induced Osteomalacia Localized and Excised After Pregnancy.
Sum M; Hoda ST; Rapp T; Zan E
AACE Clin Case Rep; 2021; 7(6):363-366. PubMed ID: 34765732
[TBL] [Abstract][Full Text] [Related]
9. Extended Whole-body Ga-68 DOTATATE PET-CT in evaluating Tumour-Induced Osteomalacia: Case report and review of literature.
Tan TH; Chen EJ; Chew MT; Chye PC; Wong M
Nucl Med Mol Imaging; 2021 Jun; 55(3):130-135. PubMed ID: 34109008
[TBL] [Abstract][Full Text] [Related]
10. Renal Phosphate Wasting Due to Tumor-Induced (Oncogenic) Osteomalacia.
Amaratunga EA; Ernst EB; Kamau J; Kotala R; Snyder R
Cureus; 2021 Jun; 13(6):e15507. PubMed ID: 34268038
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in the upper thoracic spine.
Garg B; Mehta N; Goyal A; Khadgawat R
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33328210
[TBL] [Abstract][Full Text] [Related]
12. Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes.
Zimering MB; Caldarella FA; White KE; Econs MJ
Endocr Pract; 2005; 11(2):108-14. PubMed ID: 15901526
[TBL] [Abstract][Full Text] [Related]
13. Tumour-induced osteomalacia due to an intra-abdominal mesenchymal tumour.
Krishnappa B; Jadhav SR; Lila AR; Bandgar TR
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31806630
[TBL] [Abstract][Full Text] [Related]
14. Tumor-induced osteomalacia.
Florenzano P; Gafni RI; Collins MT
Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
[TBL] [Abstract][Full Text] [Related]
15. Utility of Gallium-68 DOTANOC PET/CT in the localization of Tumour-induced osteomalacia.
Bhavani N; Reena Asirvatham A; Kallur K; Menon AS; Pavithran PV; Nair V; Vasukutty JR; Menon U; Kumar H
Clin Endocrinol (Oxf); 2016 Jan; 84(1):134-40. PubMed ID: 25996566
[TBL] [Abstract][Full Text] [Related]
16. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
Alonso G; Varsavsky M
Endocrinol Nutr; 2016 Apr; 63(4):181-6. PubMed ID: 26718193
[TBL] [Abstract][Full Text] [Related]
17. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.
Clifton-Bligh RJ; Hofman MS; Duncan E; Sim IeW; Darnell D; Clarkson A; Wong T; Walsh JP; Gill AJ; Ebeling PR; Hicks RJ
J Clin Endocrinol Metab; 2013 Feb; 98(2):687-94. PubMed ID: 23295468
[TBL] [Abstract][Full Text] [Related]
18. Phosphaturic mesenchymal tumors among elderly patients: a case report and review of literature.
Adnan Z; Nikomarov D; Weiler-Sagie M; Roguin Maor N
Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31051470
[TBL] [Abstract][Full Text] [Related]
19. Ga-68 DOTATATE Positron Emission Tomography-Computed Tomography Imaging in Oncogenic Osteomalacia: Experience from a Tertiary Level Hospital in South India.
John JR; Hephzibah J; Oommen R; Shanthly N; Mathew D
Indian J Nucl Med; 2019; 34(3):188-193. PubMed ID: 31293296
[TBL] [Abstract][Full Text] [Related]
20. Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna.
Ward LM; Rauch F; White KE; Filler G; Matzinger MA; Letts M; Travers R; Econs MJ; Glorieux FH
Bone; 2004 May; 34(5):905-11. PubMed ID: 15121023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
